Liu L, Erickson NT, Ricard I, von Weikersthal LF, et al. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized phase III trial FIRE-3 (AIO KRK-0306). Int J Cancer 2021 Aug 25. doi: 10.1002/ijc.33775.
PMID: 34431518